Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 237-248

  Sun, Yinyan ^a   Qi, Yonghe ^a,b   Liu, Chenxuan ^a   Gao, Wenqing ^a   Chen, Pan ^a,c   Fu, Liran ^a,c   Peng, Bo ^a   Wang, Haimin ^a   Jing, Zhiyi ^a   Zhong, Guocai ^a   Li, Wenhui ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GN PROTEIN; GROUP SPECIFIC COMPONENT GLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; MYOSIN IIA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BUNYAVIRUS; BUNYAVIRUS INFECTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE OVEREXPRESSION; GENE SILENCING; HOST PATHOGEN INTERACTION; IMMUNOPRECIPITATION; INFECTION SENSITIVITY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS INFECTION; UMBILICAL VEIN ENDOTHELIAL CELL; VIRUS ENTRY;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA PRIMERS; FEVER; HUMANS; MICROSCOPY, CONFOCAL; MYOSIN HEAVY CHAINS; PHLEBOVIRUS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THROMBOCYTOPENIA;

EID: 84890866452     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02141-13     Document Type: Article

References (40)

1. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, Qu J, Li Q, Zhang YP, Hai R, Wu W, Wang Q, Zhan FX, Wang XJ, Kan B, Wang SW, Wan KL, Jing HQ, Lu JX, Yin WW, Zhou H, Guan XH, Liu JF, Bi ZQ, Liu GH, Ren J, Wang H, Zhao Z, Song JD, He JR, Wan T, Zhang JS, Fu XP, Sun LN, Dong XP, Feng ZJ, Yang WZ, Hong T, Zhang Y, Walker DH, Wang Y, Li DX. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364:1523-1532. http://dx.doi.org/10.1056/NEJMoa1010095.
2. Xu B, Liu L, Huang X, Ma H, Zhang Y, Du Y, Wang P, Tang X, Wang H, Kang K, Zhang S, Zhao G, Wu W, Yang Y, Chen H, Mu F, Chen W. 2011. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 7:e1002369. http://dx.doi.org/10.1371/journal.ppat .1002369.
3. The Asahi Shimbun. 20 February 2013. Concern rises over deadly tickborne virus in Japan. ProMed-mail. http://www.promedmail.org/direct .php?id20130220.1551946.
4. Kim K-H, Yi J, Kim G, Choi SJ, Jun KI, Kim N-H, Choe PG, Kim N-J, Lee J-K, Oh M-D. 2013. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg. Infect. Dis. http://dx.doi.org/10.3201/eid1911 .130792.
5. Cui F, Cao HX, Wang L, Zhang SF, Ding SJ, Yu XJ, Yu H. 2013. Clinical and epidemiological study on severe fever with thrombocytopenia syndrome in Yiyuan County, Shandong Province, China. Am. J. Trop. Med. Hyg. 88:510-512. http://dx.doi.org/10.4269/ajtmh.11-0760.
6. Jiao Y, Zeng X, Guo X, Qi X, Zhang X, Shi Z, Zhou M, Bao C, Zhang W, Xu Y, Wang H. 2012. Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by doubleantigen sandwich enzyme-linked immunosorbent assay. J. Clin. Microbiol. 50:372-377. http://dx.doi.org/10.1128/JCM.01319-11.
7. Rusu M, Bonneau R, Holbrook MR, Watowich SJ, Birmanns S, Wriggers W, Freiberg AN. 2012. An assembly model of Rift Valley fever virus. Front. Microbiol. 3:254. http://dx.doi.org/10.3389/fmicb.2012.00254.
8. Tischler ND, Gonzalez A, Perez-Acle T, Rosemblatt M, Valenzuela PD. 2005. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J. Gen. Virol. 86:2937-2947. http://dx.doi.org/10.1099/vir.0.81083-0.
9. Plassmeyer ML, Soldan SS, Stachelek KM, Martin-Garcia J, Gonzalez-Scarano F. 2005. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Virology 338: 121-132. http://dx.doi.org/10.1016/j.virol.2005.04.026.
10. Dessau M, Modis Y. 2013. Crystal structure of glycoprotein C from Rift Valley fever virus. Proc. Natl. Acad. Sci. U. S. A. 110:1696-1701. http://dx .doi.org/10.1073/pnas.1217780110.
11. Lozach PY, Mancini R, Bitto D, Meier R, Oestereich L, Overby AK, Pettersson RF, Helenius A. 2010. Entry of bunyaviruses into mammalian cells. Cell Host Microbe 7:488-499. http://dx.doi.org/10.1016/j.chom .2010.05.007.
12. Jin M, Park J, Lee S, Park B, Shin J, Song KJ, Ahn TI, Hwang SY, Ahn BY, Ahn K. 2002. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 294:60-69. http://dx.doi.org/10.1006 /viro.2001.1303.
13. Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. 2002. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch. Virol. 147:1913-1931. http://dx.doi.org/10.1007 /s00705-002-0852-0.
14. Song JW, Song KJ, Baek LJ, Frost B, Poncz M, Park K. 2005. In vivo characterization of the integrin beta3 as a receptor for Hantaan virus cellular entry. Exp. Mol. Med. 37:121-127. http://dx.doi.org/10.1038/emm .2005.16.
15. Lozach PY, Kuhbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A. 2011. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10:75-88. http://dx.doi.org/10.1016/j.chom.2011.06.007.
16. Hofmann H, Xingxing L, Zhang X, Liu W, Kuhl A, Kaup F, Soldan SS, Gonzalez-Scarano F, Weber F, He Y, Pohlmann S. 2013. The severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as receptor for pH-dependent entry into human and animal cell lines. J. Virol. 87:4384-4394. http://dx.doi.org/10 .1128/JVI.02628-12.
17. Deutsch S, Rideau A, Bochaton-Piallat ML, Merla G, Geinoz A, Gabbiani G, Schwede T, Matthes T, Antonarakis SE, Beris P. 2003. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome. Blood 102:529-534. http://dx.doi.org/10.1182/blood-2002-09-2783.
18. Sun Y, Liang M, Qu J, Jin C, Zhang Q, Li J, Jiang X, Wang Q, Lu J, Gu W, Zhang S, Li C, Wang X, Zhan F, Yao W, Bi Z, Wang S, Li D. 2012. Early diagnosis of novel SFTS bunyavirus infection by quantitative realtime RT-PCR assay. J. Clin. Virol. 53:48-53. http://dx.doi.org/10.1016/j .jcv.2011.09.031.
19. de StGroth SF, Scheidegger D. 1980. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35:1-21. http://dx.doi.org /10.1016/0022-1759(80)90146-5.
20. Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y. 2010. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467:859-862. http://dx.doi.org/10.1038/nature09420.
21. Bao J, Jana SS, Adelstein RS. 2005. Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis. J. Biol. Chem. 280:19594-19599. http://dx.doi.org/10.1074/jbc .M501573200.
22. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. 2009. Nonmuscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 10:778-790. http://dx.doi.org/10.1038/nrm2786.
23. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu. Rev. Biochem. 79:803-833. http://dx.doi.org/10.1146/annurev -biochem-060208-104626.
24. Heissler SM, Manstein DJ. 2013. Nonmuscle myosin-2: mix and match. Cell. Mol. Life Sci. 70:1-21. http://dx.doi.org/10.1007/s00018-012-1002-9.
25. Rey M, Vicente-Manzanares M, Viedma F, Yanez-Mo M, Urzainqui A, Barreiro O, Vazquez J, Sanchez-Madrid F. 2002. Cutting edge: association of the motor protein nonmuscle myosin heavy chain-IIA with the C terminus of the chemokine receptor CXCR4 in T lymphocytes. J. Immunol. 169:5410-5414. http://www.jimmunol.org/content/169/10/5410.full.
26. Rey M, Valenzuela-Fernandez A, Urzainqui A, Yanez-Mo M, Perez-Martinez M, Penela P, Mayor F, Jr, Sanchez-Madrid F. 2007. Myosin IIA is involved in the endocytosis of CXCR4 induced by SDF-1alpha. J. Cell Sci. 120:1126-1133. http://dx.doi.org/10.1242/jcs.03415.
27. Burckhardt CJ, Greber UF. 2009. Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog. 5:e1000621. http://dx.doi.org/10.1371/journal.ppat.1000621.
28. Schelhaas M, Ewers H, Rajamaki ML, Day PM, Schiller JT, Helenius A. 2008. Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog. 4:e1000148. http://dx.doi .org/10.1371/journal.ppat.1000148.
29. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. http://dx.doi .org/10.1126/science.1155164.
30. Cudmore S, Cossart P, Griffiths G, Way M. 1995. Actin-based motility of vaccinia virus. Nature 378:636-638. http://dx.doi.org/10.1038/378636a0.
31. Lehmann MJ, Sherer NM, Marks CB, Pypaert M, Mothes W. 2005. Actin-and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell Biol. 170:317-325. http://dx.doi.org/10.1083 /jcb.200503059.
32. Laliberte JP, Weisberg AS, Moss B. 2011. The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog. 7:e1002446. http://dx.doi.org/10 .1371/journal.ppat.1002446.
33. Chen Y, Takizawa N, Crowley JL, Oh SW, Gatto CL, Kambara T, Sato O, Li XD, Ikebe M, Luna EJ. 2003. F-actin and myosin II binding domains in supervillin. J. Biol. Chem. 278:46094-46106. http://dx.doi .org/10.1074/jbc.M305311200.
34. Fang Z, Takizawa N, Wilson KA, Smith TC, Delprato A, Davidson MW, Lambright DG, Luna EJ. 2010. The membrane-associated protein, supervillin, accelerates F-actin-dependent rapid integrin recycling and cell motility. Traffic 11:782-799. http://dx.doi.org/10.1111/j.1600-0854.2010.01062.x.
35. Balduini CL, Pecci A, Savoia A. 2011. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br. J. Haematol. 154:161-174. http://dx.doi.org/10.1111/j.1365-2141.2011.08716.x.
36. Althaus K, Najm J, Greinacher A. 2011. MYH9 related platelet disorders-often unknown and misdiagnosed. Klin. Padiatr. 223:120-125. http://dx.doi.org/10.1055/s-0031-1275664.
37. Althaus K, Greinacher A. 2010. MYH-9 related platelet disorders: strategies for management and diagnosis. Transfus. Med. Hemother. 37:260-267.
38. Althaus K, Greinacher A. 2009. MYH9-related platelet disorders. Semin. Thromb. Hemost. 35:189-203. http://dx.doi.org/10.1055/s-0029-1220327.
39. Kunishima S, Hamaguchi M, Saito H. 2008. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders. Blood 111:3015-3023. http://dx.doi.org/10.1182/blood-2007-10-116194.
40. Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, Zhang F, Li C, Zhang Q, Zhu H, Chen T, Han Y, Zhang W, Zhang S, Wang Q, Sun L, Liu Q, Li J, Wang T, Wei Q, Wang S, Deng Y, Qin C, Li D. 2012. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/ BL6 mouse model. Proc. Natl. Acad. Sci. U. S. A. 109:10053-10058. http: //dx.doi.org/10.1073/pnas.1120246109.